STAAR Surgical shareholders approve 3.9 million share increase to equity incentive plan
At its June 18, 2026 annual meeting, STAAR Surgical shareholders approved Amendment No. 2 to the company's Omnibus Equity Incentive Plan, increasing the shares reserved for issuance under the plan by 3,900,000. Shareholders also elected all seven director nominees, ratified BDO USA as auditor, and approved the advisory vote on executive compensation. The plan increase adds shares available for equity awards, which can dilute existing shareholders' ownership.
Key points
- Plan amendment approved: 40,231,475 votes for, 974,989 against, 67,857 abstentions, and 2,406,114 broker non-votes.
- All seven directors elected to terms expiring at the 2027 annual meeting; Neal C. Bradsher received 40,776,719 votes for.
- BDO USA, P.C. ratified as independent auditor for the fiscal year ending January 1, 2027, with 43,433,234 votes for.
- Quorum of 43,680,435 of 49,788,295 outstanding shares as of the April 20, 2026 record date.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 22, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.